Biomarkers such as chromogranin A play an important role in the diagnosis and follow-up of patients with neuroendocrine tumors. Molecular imaging, including somatostatin receptor scintigraphy but ...

Biomarkers such as chromogranin A play an important role in the diagnosis and follow-up of patients with neuroendocrine tumors. Molecular imaging, including somatostatin receptor scintigraphy but ...

18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a strong prognosis predictor for neuroendocrine tumors, according to new research from scientists at the Rigshospitalet, Copenhagen.

The team treats hundreds of patients with neuroendocrine tumors each year. Gastrointestinal neuroendocrine tumors are often difficult to diagnose. Many of these tumors do not cause noticeable symptoms ...

43rd Annual J.P. Morgan Healthcare Conference – Company Presentation Date: Wednesday, January 15, 2025 Time: 3:45 p.m. - 4:25 p.m. PT Location: The Westin St. Francis Hotel, San Francisco, CA ...

A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat ...

Dordaviprone hydrochloride is under clinical development by Chimerix and currently in Phase I for Prostate Cancer.